SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-24-000152
Filing Date
2024-10-31
Accepted
2024-10-31 15:01:13
Documents
79
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20240930.htm   iXBRL 10-Q 1619364
2 EX-10.2 bmrn-exx102xq32024.htm EX-10.2 17109
3 EX-31.1 bmrn-exx311xq32024.htm EX-31.1 9229
4 EX-31.2 bmrn-exx312xq32024.htm EX-31.2 9242
5 EX-32.1 bmrn-exx321xq32024.htm EX-32.1 5141
  Complete submission text file 0001048477-24-000152.txt   7831736

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20240930.xsd EX-101.SCH 46000
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20240930_cal.xml EX-101.CAL 77097
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20240930_def.xml EX-101.DEF 229138
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20240930_lab.xml EX-101.LAB 589203
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20240930_pre.xml EX-101.PRE 421131
82 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20240930_htm.xml XML 1302273
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 241414803
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)